1-3 of 3
Beverly Teicher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Single Mouse Trial Platform for Evaluation of Novel Agents in Acute Lymphoblastic Leukemia By the Pediatric Preclinical Testing Consortium

Richard B. Lock, PhD, Kathryn Evans, Tara Pritchard, Cara Toscan, Chelsea Mayoh, Beverly Teicher, Raushan T Kurmasheva, Peter J Houghton, Malcolm Smith, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4010.
https://doi.org/10.1182/blood-2018-99-113207
Published: 2018
Journal Articles

Defibrotide (DF), an Orally Bioavailable Modulator of Myeloma Tumor-Microenvironment Interactions: Molecular Sequelae and Clinical Implications.

Constantine S. Mitsiades, Luba Benimetskaya, Krishna Menon, Cinara Echart, Cecile Rouleau, Beverly Teicher, Antonio Palumbo, Mario Boccadoro, Massimo Iacobelli, Kenneth C. Anderson, Cy A. Stein, Paul G. Richardson
Journal: Blood
Blood (2006) 108 (11): 3523.
https://doi.org/10.1182/blood.V108.11.3523.3523
Published: 2006
Journal Articles

Defibrotide (DF) Targets Tumor-Microenvironmental Interactions and Sensitizes Multiple Myeloma and Solid Tumor Cells to Cytotoxic Chemotherapeutics.

Constantine S. Mitsiades, MD, PhD, Cecile Rouleau, PhD, Krishna Menon, PhD, Beverly Teicher, PhD, Massimo Iacobelli, MD, Kenneth C. Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2004) 104 (11): 286.
https://doi.org/10.1182/blood.V104.11.286.286
Published: 2004